1,7-Dioxacycloheptadecan-8-one
Common Name: |
1,7-Dioxacycloheptadecan-8-one |
IUPAC Name: |
1,7-dioxacycloheptadecan-8-one |
Molecular Formula: |
C15H28O3 |
SMILES: |
C1CCCCC(=O)OCCCCCOCCCC1 |
Inchi: |
1S/C15H28O3/c16-15-11-7-4-2-1-3-5-8-12-17-13-9-6-10-14-18-15/h1-14H2 |
Inchi Key: |
MKEIDVFLAWJKMY-UHFFFAOYSA-N |
Cas No: |
3391-83-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
256.38 |
Mass (g/mol) |
256.204 |
Molar Refractivity |
74.47 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
18 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
30.00 |
Boiling Point (°C@760.00mm Hg) |
411.13 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.93 |
LogP |
3.851 |
iLOGP |
2.96 |
XLOGP3 |
3.99 |
WLOGP |
3.85 |
MLOGP |
2.67 |
ESOL Log S |
-3.94 |
ESOL Solubility (mg/ml) |
0.029 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.44 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.43 |
Silicos-IT Solubility (mg/ml) |
0.09 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.03 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.724 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.794 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |